Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1Stomach Neoplasms 1Opioid-Related Disorders 1Nausea 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anorexia 1

Interventions

Ultrasonic Waves 1Tirzepatide 1Standard of Care 1Olanzapine 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Opioid-Related Disorders × Olanzapine × 90 days × Clear all
NCT06200181 2026-06-01

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

M.D. Anderson Cancer Center

Phase 3 Recruiting
87 enrolled

Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡